EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. (IST:ECILC)

EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. Company Description

EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S., together with subsidiaries, engages in health and real estate development businesses in Turkey and internationally.

The Health segment produces and sells human health and veterinary medicines, as well as engages in pharmaceutical sales and marketing.

Its Real Estate Development segment develops real estate properties; engages in leasing activities for serum facilities; and provides consulting services on land development and project management.

The company was incorporated in 1951 and is based in Istanbul, Turkey. EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. is a subsidiary of Eczacibasi Holding A.S.

EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.

Country	Turkey
Founded	1951
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	1,144
CEO	Muge Satir

Contact Details

Address: Büyükdere Cad. Istanbul, 34394 Turkey
Phone	90 212 350 80 00
Website	eis.com.tr

Stock Details

Ticker Symbol	ECILC
Exchange	Istanbul Stock Exchange
Fiscal Year	January - December
Reporting Currency	TRY
ISIN Number	TRAECILC91E0
SIC Code	2834

Key Executives

Name	Position
Dr. Erdal Osman Karamercan	President and Chief Executive Officer of Eczacibai Holding AS
Rahmi Faruk Bulent Eczacibasi	Vice Chairman and Deputy Chief Executive Officer
Muge Satir	Acting General Manager
Levent Avni Ersalman	President of Strategic Planning and Financing Group
Simay Agacdiken Unal	Investor Relations Manager
Ülkü Feyyaz Taktak	Vice President of Human Resources
Mustafa Sacit Basmaci	President of Financial Affairs Group